Clinical Trials
9 trialsNCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT04475029 2023-09-13
METAMORF
University of Aarhus
Phase NA Completed
NCT00003687 2020-04-03
Treatment for Chronic Pain in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00446069 2016-08-29
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
Egalet Ltd
Phase 2 Completed
NCT00003000 2015-10-14
Morphine for the Treatment of Pain in Patients With Breast Cancer
Roswell Park Cancer Institute
Completed
NCT00378937 2013-08-02
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
National Cancer Institute (NCI)
Phase 4 Completed
NCT00020618 2013-07-18
Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain
National Cancer Institute (NCI)
Phase 2 Completed
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed
NCT00410540 2010-04-27
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Alza Corporation, DE, USA
Phase 3 Completed